Equity Market Structural Shift: Why Real Assets Are Surging Past Financials as FII Focus Changes

Equity Market Structural Shift: Why Real Assets Are Surging Past Financials as FII Focus Changes​

India's equity market appears poised for a significant structural transition. The traditional role of financials as the default proxy for India's economic growth is steadily eroding, according to Avendus Wealth Management. This shift signifies that investors are actively broadening their focus beyond legacy sectors in pursuit of genuine growth drivers.

The Decline of Financials as an Investment Proxy​

For years, financial stocks were a primary way for global investors to gain exposure to the Indian economy. When India was viewed as a smaller component of the worldwide investment scene, buying financials offered a direct route into economic expansion. However, this narrative is fundamentally changing in a maturing market.

Experts suggest that financials may lose their critical bottom-up relevance over the next decade. Large banks are unlikely to generate extraordinary returns unless significant mergers or major structural shifts occur within the sector. Consequently, their increasing weight in indices will likely experience a gradual decline.

The banking segment itself has recently seen diminished momentum despite periodic trading rallies. With most institutional investors already holding stakes in various banks, generating surprise positive movements has become difficult for the sector.

Real Assets Emerge as New Growth Driver​

Investor interest is rapidly migrating towards real assets. These include crucial sectors such as manufacturing, ports, airports, and mining. While financials were once a primary focus, the investment landscape today requires looking much further afield.

In comparison to five or seven years ago, when traditional allocations often covered 30% in banks, 20% in IT, and 10% in Reliance, indices are now far more diverse. The market is actively moving beyond these established sectors.

This redirection of capital means the composition of the index itself will look distinctly different in the coming years. Value is starting to emerge in specific pockets within industrials and manufacturing.

FII Inflows Anticipated Amid Global Shift​

There are clear signs indicating a positive shift in foreign investor behavior. Within the next six months, Foreign Institutional Investors (FIIs) are expected to return with reasonable inflows into India. Currently, India's weightage in MSCI stands around 11%, which experts view as unsustainable given the nation's massive population base.

A distinction is being made between benchmark-hugging FIIs and smarter institutional investors. These smarter funds are already executing large block transactions in certain stocks. This represents a decisive movement toward investing in real economic assets.

This inflow of capital is necessary because money must be allocated after cycles of fatigue have set in across other global markets, including parts of China, Korea, and Taiwan. Given that these markets are not straightforwardly investable right now, money flows back to India.

Market Outlook: IT, Pharma, and Geopolitical Fatigue​

The current market environment shows a distinct level of geopolitical fatigue. Markets have begun reacting less intensely to global conflicts and more to localized developments such as AI advancements and IPO news related to SpaceX. Investors are collectively working through the next couple of quarters to assess for permanent damage.

However, crude oil remains the primary variable influencing the broader economy. Historically, once oil prices reach $110-$120 a barrel, demand destruction begins, leading businesses to cut costs.

There remain genuine and significant investment opportunities should FIIs re-enter the market. Large private banks could see potential rallies of 10-15%. Similarly, IT stocks are viewed as having the capacity for a similar 10-15% rally upon healthy FII returns.

Regarding technology, experts state that AI disruption is real but does not necessarily justify existential fears about the industry. While companies like Infosys and TCS are essential to implementing AI changes, it is also noted that a correction in IT was due after prior valuations.

For pharmaceutical stocks, which represent a broad segment, continued focus must be placed on individual business verticals such as innovation-led drug development or CDMOs. The ultimate question for the market's next direction lies with Corporate India’s operational clarity in July regarding current disruptions.